Nedermaas Hightech Ventures
8
5M
7
1
0.12
2
- Stages of investment
- Areas of investment
Summary
The venture was found in Europe in The Netherlands. The main office of represented VC is situated in the Maastricht.
We can highlight the next thriving fund investment areas, such as Life Science, Chemical. Among the various public portfolio startups of the fund, we may underline BioActor, Phenospex, Ekompany Besides, a startup needs to be aged 4-5 years to get the investment from the fund. For fund there is a match between the country of its foundation and the country of its the most frequent investments - The Netherlands. The fund has specific favorite in a number of founders of portfolio startups.
The usual cause for the fund is to invest in rounds with 4-5 partakers. Despite the Nedermaas Hightech Ventures, startups are often financed by Thuja Capital, EASME - EU Executive Agency for SMEs, Disruptive Capital Finance. The meaningful sponsors for the fund in investment in the same round are Limburg Ventures, NV Industriebank LIOF, Chemelot Ventures. In the next rounds fund is usually obtained by NV Industriebank LIOF, Horizon 2020, Future Food Fund.
The top activity for fund was in 2011. Speaking about the real fund results, this VC is 8 percentage points less often commits exit comparing to other organizations. Deals in the range of 5 - 10 millions dollars are the general things for fund. Comparing to the other companies, this Nedermaas Hightech Ventures performs on 4 percentage points less the average number of lead investments. The fund is constantly included in less than 2 investment rounds annually. The higher amount of exits for fund were in 2016.
Investments analytics
Analytics
- Total investments
- 8
- Lead investments
- 1
- Exits
- 2
- Follow on index
- 0.12
- Investments by industry
- Biotechnology (6)
- Life Science (4)
- Therapeutics (3)
- Genetics (2)
- Pharmaceutical (2) Show 7 more
- Investments by region
-
- Netherlands (6)
- United Kingdom (1)
- France (1)
- Peak activity year
- 2011
Discover reliable insights
Leverage validated data, identify key contacts and secure funding opportunities for your business.Quantitative data
- Avg. startup age at the time of investment
- 13
- Group Appearance index
- 1.00
- Avg. company exit year
- 8
Need more data?
Get access to full data about investors, including their team, contact information, and historic data.
Latest deals
Company name | Deal date | Industry | Deal stage | Deal size | Location |
---|---|---|---|---|---|
Q Chip | 20 May 2011 | Biotechnology, Life Science, Therapeutics | Late Stage Venture | 6M | United Kingdom, Wales, Cardiff |
Similar funds
By same location
By same geo focus
By doing lead investments
At Unicorn Nest, we combine cutting-edge technology with human expertise to build one of the most reliable venture capital databases in the market. Our process begins with automated AI-enhanced data collection, leveraging the full potential of Large Language Models (LLMs).
Later, our team of analysts takes it further with manual verification, using proprietary tools for data cleaning and validation to ensure accuracy and reliability. We cross-check and enhance our findings through press and media monitoring, integrating information from trusted news outlets and venture capital aggregators. Finally, we stay ahead of the curve by monitoring social networks like LinkedIn and X.com.